Literature DB >> 29110805

A Population-Based Epidemiologic Study of Female Sexual Dysfunction Risk in Mainland China: Prevalence and Predictors.

Chunni Zhang1, Jiali Tong2, Lan Zhu3, Lei Zhang2, Tao Xu4, Jinghe Lang2, Yu Xie5.   

Abstract

BACKGROUND: Epidemiologic data on female sexual dysfunction in China are sparse. AIM: To assess the prevalence of risk of female sexual dysfunction in mainland China and its regional and sociodemographic variations and physiologic, pathologic, and behavioral risk factors.
METHODS: A survey of the general female population was conducted in mainland China from February 2014 through January 2016. Women were randomly selected using multistage, stratified, cluster sampling. The prevalence rate of sexual dysfunction, as measured by the Female Sexual Function Index and a score lower than 23.45 as the cutoff threshold, was determined. Multivariate logistical regression models were used to examine the effects of sociodemographic, physiologic, pathologic, and behavioral factors on women's risk of experiencing sexual dysfunction and domain-specific sexual problems. OUTCOMES: The questionnaire on sexual dysfunction was completed by 25,446 women 20 to 70 years old.
RESULTS: The prevalence of sexual dysfunction in women 20 to 70 years old in mainland China was estimated at 29.7% (99% CI = 28.9-30.4), with large regional variations. The prevalence rates of potential domain-specific sexual problems were 21.6% (99% CI = 20.9-22.2) for low desire, 21.5 (99% CI = 20.8-22.2) for arousal disorder, 18.9% (99% CI = 18.3-19.6) for lubrication disorder, 27.9% (99% CI = 27.2-28.7) for orgasm disorder, and 14.1% (99% CI = 13.6-14.7) for sexual pain. Higher educational attainment and urban residency were associated with a decreased risk of sexual dysfunction. Women of ethnic minorities (or non-Han ethnicity) had fewer reports of sexual dysfunction than women of Han ethnicity (odds ratio = 0.67, 99% CI = 0.47-0.97). Diabetes, cancers, pelvic inflammatory disease, and pelvic organ prolapse significantly increased the reports of sexual dysfunction. CLINICAL TRANSLATION: This survey provided the prevalence and risk factors of female sexual dysfunction in China, information that could be useful for potential prevention and clinical treatment. STRENGTHS AND LIMITATIONS: This is the first large-scale, nationally based epidemiologic study of female sexual dysfunction in mainland China. The limitations of the study design included an overpowered study caused by the large sample, the under-representation of younger and unmarried women, and no information on the women's partners, their values and knowledge, and detailed medical conditions.
CONCLUSIONS: The prevalence rate of female sexual dysfunction in mainland China was modest overall, although variations existed across regions and social groups. Zhang C, Tong J, Zhu L, et al. A Population-Based Epidemiologic Study of Female Sexual Dysfunction Risk in Mainland China: Prevalence and Predictors. J Sex Med 2017;14:1348-1356.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  China; Female Sexual Dysfunction; Prevalence; Risk Factors

Mesh:

Year:  2017        PMID: 29110805     DOI: 10.1016/j.jsxm.2017.08.012

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  10 in total

1.  Remission and Transition of Female Urinary Incontinence and Its Subtypes and the Impact of Body Mass Index on This Progression: A Nationwide Population-Based 4-Year Longitudinal Study in China.

Authors:  Haiyu Pang; Tao Xu; Zhaoai Li; Jian Gong; Qing Liu; Yuling Wang; Juntao Wang; Zhijun Xia; Lan Zhu
Journal:  J Urol       Date:  2022-04-15       Impact factor: 7.600

2.  An epidemiologic study on symptomatic pelvic organ prolapse in obese Chinese women: a population-based study in China.

Authors:  Zhiyi Li; Tao Xu; Zhaoai Li; Jian Gong; Qing Liu; Yulin Wang; Juntao Wang; Zhijun Xia; Lan Zhu
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-16       Impact factor: 3.168

3.  Psychiatric disorders in female psychosexual disorders-a nationwide, cohort study in Taiwan : Psychiatric disorders and female psychosexual disorders.

Authors:  Iau-Jin Lin; Nian-Sheng Tzeng; Chi-Hsiang Chung; Wu-Chien Chien
Journal:  BMC Psychiatry       Date:  2021-01-28       Impact factor: 3.630

4.  Knowledge, Attitudes, and Practice Patterns Relating to Female Sexual Health Among Obstetricians and Gynecologists in China.

Authors:  Guanjian Li; Chao Wang; Bin Song; Runju Zhang; Dan Zhang; Xiaojin He; Yunxia Cao
Journal:  JAMA Netw Open       Date:  2021-05-03

5.  The Relationship Between Pelvic Floor Function and Sexual Function in Perimenopausal Women.

Authors:  Zhihong Zhuo; Chuhan Wang; Huimin Yu; Jing Li
Journal:  Sex Med       Date:  2021-10-07       Impact factor: 2.491

6.  Incidence and risk factors of female urinary incontinence: a 4-year longitudinal study among 24 985 adult women in China.

Authors:  H Pang; J Lv; T Xu; Z Li; J Gong; Q Liu; Y Wang; J Wang; Z Xia; Z Li; L Li; L Zhu
Journal:  BJOG       Date:  2021-10-17       Impact factor: 7.331

7.  How Is the Sexual Function of Premenopausal Chinese Women Without Hyperlipidemia?

Authors:  Yali Xiang; Yuxin Tang; Jiaqun Li; Dongjie Li
Journal:  Sex Med       Date:  2019-12-16       Impact factor: 2.491

8.  Female sexual dysfunction among married women in the Gaza Strip: an internet-based survey.

Authors:  Raziyeh Maasoumi; Aymen Elsous; Hawawu Hussein; Ziba Taghizadeh; Suha Baloushah
Journal:  Ann Saudi Med       Date:  2019-10-03       Impact factor: 1.526

9.  Anxiety symptoms in patients with Mayer-Rokitansky-Küster-Hauser syndrome: a cross-sectional study.

Authors:  Shuang Song; Na Chen; Yan-Ping Duan; Jia Kang; Shan Deng; Hong-Xin Pan; Lan Zhu
Journal:  Chin Med J (Engl)       Date:  2020-02-20       Impact factor: 2.628

10.  Overexpressing miR-122-5p Inhibits the Relaxation of Vaginal Smooth Muscle in Female Sexual Arousal Disorder by Targeting Vasoactive Intestinal Peptide Receptor 1.

Authors:  Shengnan Cong; Tao Gui; Qinchuan Shi; Jingjing Zhang; Jingyi Feng; Lianjun Pan; Jiehua Ma; Aixia Zhang
Journal:  Sex Med       Date:  2021-07-08       Impact factor: 2.491

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.